Showing 7091-7100 of 23148 results for "".
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/biomarker-guided-treatment-er-her2-metastatic-breast-cancer/39723/Biomarker testing has become a cornerstone of personalized care in ER-positive, HER2-negative (ER+, HER2-) metastatic breast cancer, shaping how therapies are selected and sequenced over time. Advances in genomic profiling are improving our understanding of treatment resistance and enabling more preMASLD and MASH in Focus: Clinical Priorities and Promising Pathways
https://reachmd.com/programs/clinicians-roundtable/masld-mash-clinical-priorities-pathways/39659/From early metabolic risks to advanced liver disease, the progressive burden associated with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) requires timely, informed care. Hear from Dr. Peter Buch as he shares practical guUnmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
https://reachmd.com/programs/project-oncology/unmet-needs-endometrial-cancer-treatment-equity/39929/Endometrial cancer is rising in incidence, with mortality now surpassing that of ovarian cancer. Hear from Dr. Brian Slomovitz as he explores evolving molecular classifications, treatment challenges, and the urgent need to address racial disparities in care. Dr. Slomovitz is the Director of GynecoloTreating Psoriasis Patients Who Vape: Barriers and Interventions
https://reachmd.com/programs/clinicians-roundtable/treating-psoriasis-patients-who-vape-barriers-and-interventions/36368/For dermatologists, treating psoriasis patients who use e-cigarettes can be challenging, particularly because of a lack of education about its risks, mental health concerns, and impacts on treatment efficacy. That being said, there are ways to address these challenges to support patients and improveJournal Club: Colloidal Oat for Prevention and Treatment
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-colloidal-oat-for-prevention-and-treatment/32407/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Lawrence Eichenfield, MD, FAAD, discuss a study demonstrating the benefits of oat for infant skincare, especially for the treatment and mitigation of atopic dermatitis.COVID-19 Recovery: Investigating the Link Between Inflammation and Cognitive Symptoms
https://reachmd.com/programs/clinicians-roundtable/covid-19-recovery-investigating-the-link-between-inflammation-and-cognitive-symptoms/35465/A post hoc analysis of the CONTAIN randomized clinical trial tracked inflammatory markers and health outcomes up to 18 months post-hospitalization. Based on the results, markers like cytokines, D-dimer, and fibrinogen declined over time, and no clear link was found between persistent inflammation anLaunching Your Private Practice: Key Steps for Success
https://reachmd.com/ma-issues-index/2025-may-june/launching-your-private-practice-key-steps-for-success/36075/An engaging session with Dr. Michael SomenekExploring the Clinical Treatments of Schizophrenia
https://reachmd.com/programs/neurofrontiers/exploring-the-clinical-treatments-of-schizophrenia/18086/What class of medications treat schizophrenia, particularly psychosis? Dive into this program to learn more.Make a Statement
https://reachmd.com/topics/practice-development/make-a-statement/35214/Tips and inspiration for writing your brand’s mission, vision, and core values statementsA Look at Emerging Virtual Reality Tools in Gastroenterology
https://reachmd.com/programs/gi-insights/a-look-at-emerging-virtual-reality-tools-in-gastroenterology/13732/How can technology make us better clinicians? Here are the latest artificial intelligence and virtual reality advances in gastroenterology.